GGrantIndex
Sort

17,288 grants matching multiple sclerosis

Transcriptional regulation of inflammatory and autoimmune responses

$793,298
Vanja Lazarevic · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA

The role of BAF related complexes in regulatory T cell development and function

$792,780
Ye Zheng · Salk Institute For Biological Studies · R01 · FY2021 · AI

The role of BAF related complexes in regulatory T cell development and function

$792,780
Ye Zheng · Salk Institute For Biological Studies · R01 · FY2022 · AI

The role of BAF related complexes in regulatory T cell development and function

$792,780
Ye Zheng · Salk Institute For Biological Studies · R01 · FY2020 · AI

The role of BAF related complexes in regulatory T cell development and function

$792,780
Ye Zheng · Salk Institute For Biological Studies · R01 · FY2023 · AI

The role of BAF related complexes in regulatory T cell development and function

$792,780
Ye Zheng · Salk Institute For Biological Studies · R01 · FY2024 · AI

Collagen-related diseases

$792,684
Sergey Leikin · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2012 · HD

Sensory motor transformations in human cortex

$792,629
Richard A Andersen · California Institute Of Technology · U01 · FY2024 · NS

p53, Aging, and Cancer

$792,614
Curtis Harris · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA

Project 3: Identifying transcriptional driver genes and targeting transcription in TSC

$792,435
David J. Kwiatkowski · Brigham And Women'S Hospital · P01 · FY2023 · CA

A microphysiologic multicellular organ-on-chip to inform clinical trials in FTD/ALS

$792,246
Clive Niels Svendsen · Cedars-Sinai Medical Center · UH3 · FY2022 · TR

Antigen Presentation in Human Autoimmune Diseases

$791,536
Dana-Farber Cancer Institute · P01 · FY2004 · AI

TNF-receptors and programmed cell death in regulation of autoimmunity

$791,146
Richard M Siegel · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · ZIA · FY2014 · AR

Long Acting Beta Interferon for Treating Multiple Sclerosis - Phase II Continuing

$790,800
George Norbert Cox · Bolder Biotechnology, Inc. · R44 · FY2009 · NS

LONGITUDINAL EVALUATION OF THE RELATION OF IMAGING MEASURES TO COGNITIVE DECLINE IN MULTIPLE SCLEROSIS

$790,789
The Cleveland Clinic Foundation · · FY2016 · Department of the Army

Disruption of Nucleocytoplasmic Transport in FUS-related Neurodegenerative Diseases

$790,424
Daryl A Bosco · Univ Of Massachusetts Med Sch Worcester · R01 · FY2022 · NS

Metabolic targeting of CD4 T cells in CNS autoimmunity

$790,222
Russell Jones · Van Andel Research Institute · R01 · FY2025 · AI

Protection against early SIV brain injury with adjunctive therapy to cART

$790,121
Dennis Larry Kolson · University Of Pennsylvania · R01 · FY2025 · NS

Endothelial monoamine neurotransmitter metabolism at the blood-brain barrier

$790,000
Roeben Munji · University Of California, San Diego · RF1 · FY2025 · MH

The Relationship Between Brain Macrophages and Cognitive Dysfunction in Systemic Lupus Erythematosus

$789,602
Carla M Cuda · Northwestern University At Chicago · R01 · FY2023 · AI

Characterization of the cellular and molecular bases of inborn errors of immunity

$789,400
Luigi Notarangelo · National Institute Of Allergy And Infectious Diseases · ZIA · FY2025 · AI

Interventions to Improve Memory in Patients with MS

$788,661
State University New York Stony Brook · R01 · FY2004 · HD

Nuclear pore complex quality control in ALS/FTD

$788,313
Jeffrey D Rothstein · Johns Hopkins University · R01 · FY2021 · NS

Para-Vascular Basis of Small Vessel Disease

$787,623
Maiken Nedergaard · University Of Rochester · R01 · FY2016 · NS

Integrating spatial multi-omics and clinical covariates to identify mechanisms of disease in ALS-FTD

$787,330
Hemali Phatnani · New York Genome Center · R01 · FY2022 · NS